We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

WBRT & Erlotinib in Advanced NSCLC and Brain Metastases (TACTIC)

This study has been terminated.
(IDMC made a recommendation to stop the trial as the target for continuing to the 2nd phase was not met.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00554775
First Posted: November 7, 2007
Last Update Posted: December 12, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Cancer Research UK
Roche Pharma AG
Information provided by (Responsible Party):
University College, London
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2010
  Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)